Investing Ideas
/
Indian Pharmaceuticals & Biotech Net Cash Stocks With A Growth Track Record

Indian Pharmaceuticals & Biotech Net Cash Stocks With A Growth Track Record

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

These companies have grown profits at a double digit rate for 5 years or more. And they have net cash.

9 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
500488 Abbott India	₹26,532.60	-4.1%	3.7%	₹563.8b	₹29,052.86	PE43.9x	E11.3%	1.5%
500660 GlaxoSmithKline Pharmaceuticals	₹2,062.95	-3.4%	-5.7%	₹349.5b	₹2,914.50	PE51.8x	E16.4%	1.6%
CONCORDBIO Concord Biotech	₹1,980.75	-8.7%	42.9%	₹207.2b	₹2,171.00	PE63.2x	E27.0%	0.4%
506820 AstraZeneca Pharma India	₹7,007.65	0.8%	11.0%	₹175.2b	n/a	PE213.9x	n/a	0.3%
INDGN Indegene	₹611.40	-9.3%	n/a	₹146.3b	₹684.00	PE39.2x	E17.5%	n/a
RPGLIFE RPG Life Sciences	₹2,272.10	4.5%	40.2%	₹37.6b	n/a	PE47.5x	n/a	0.7%
524731 Jenburkt Pharmaceuticals	₹1,160.90	-6.8%	34.6%	₹5.1b	n/a	PE16.9x	n/a	1.3%
524506 Coral Laboratories	₹749.50	-5.9%	70.0%	₹2.7b	n/a	PE11.6x	n/a	0.3%
PAR Par Drugs and Chemicals	₹196.31	0.7%	-4.8%	₹2.4b	n/a	PE13.2x	n/a	0%

Page 1 of 1